Evidence-Based Medicine Guidelines
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ovarian Suppression for Adjuvant Treatment of Hormone Receptor‐positive Early Breast Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor‐positive_early_breast_cancer.
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor‐positive_early_breast_cancer. Accessed March 27, 2025.
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor‐positive_early_breast_cancer
Ovarian Suppression for Adjuvant Treatment of Hormone Receptor‐positive Early Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor‐positive_early_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
ID - 1305349
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor‐positive_early_breast_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
